Shay Capital’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $218K | Buy |
19,382
+1,124
| +6% | +$12.6K | 0.03% | 199 |
|
2025
Q1 | $104K | Sell |
18,258
-4,411
| -19% | -$25.1K | 0.02% | 204 |
|
2024
Q4 | $223K | Buy |
+22,669
| New | +$223K | 0.03% | 192 |
|
2024
Q3 | – | Sell |
-3,331
| Closed | -$44.5K | – | 278 |
|
2024
Q2 | $44.5K | Buy |
3,331
+2,224
| +201% | +$29.7K | 0.01% | 207 |
|
2024
Q1 | $51.4K | Buy |
1,107
+431
| +64% | +$20K | 0.01% | 256 |
|
2023
Q4 | $45.7K | Hold |
676
| – | – | 0.01% | 180 |
|
2023
Q3 | $49K | Sell |
676
-55
| -8% | -$3.98K | 0.01% | 220 |
|
2023
Q2 | $54.4K | Hold |
731
| – | – | 0.01% | 251 |
|
2023
Q1 | $38.9K | Buy |
731
+376
| +106% | +$20K | 0.01% | 245 |
|
2022
Q4 | $24K | Buy |
+355
| New | +$24K | 0.01% | 179 |
|
2022
Q3 | – | Sell |
-301
| Closed | -$29K | – | 290 |
|
2022
Q2 | $29K | Buy |
+301
| New | +$29K | 0.01% | 235 |
|